Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02VDD
|
|||
| Drug Name |
Deuterated 3-cyanoquinoline derivative 1
|
|||
| Synonyms |
PMID25656651-Compound-45
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H34ClN5O3
|
|||
| Canonical SMILES |
CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4C5CC5)Cl)OC)C#N)OC
|
|||
| InChI |
1S/C29H34ClN5O3/c1-34-8-10-35(11-9-34)7-4-12-38-28-15-24-22(14-27(28)37-3)29(20(17-31)18-32-24)33-25-16-26(36-2)23(30)13-21(25)19-5-6-19/h13-16,18-19H,4-12H2,1-3H3,(H,32,33)/i1D
|
|||
| InChIKey |
YHGWVQSJPYSYIE-MICDWDOJSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.